Podcast thumbnail for NDM Public Engagement

NDM Public Engagement

Claim This Podcast

by Oxford University

10 episodes
Updated Daily
Accepts GuestsHas SponsorsLocation 🇬🇧

Podcast Overview

The NDM recognises that public engagement is vital in order to educate, inform and build a relationship with the community. Our scientists are actively engaging in open discussion, and meeting people to debate, listen and learn.

Language

🇺🇲

Publishing Since

7/16/2013

1 verified contact email on file for NDM Public Engagement

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for PITCH-2 study Protective Immunity from T Cells to Covid-19 in Health Workers - 2

July 13, 2023

PITCH-2 study Protective Immunity from T Cells to Covid-19 in Health Workers - 2

PITCH-2 (Protective Immunity from T cell Cells in Healthcare workers) is an exciting project that seeks to understand the role of T cell immunity in protection against the COVID-19 in healthcare workers. PITCH-2 (Protective Immunity from T cell Cells in Healthcare workers) is a national consortium study led by the University of Oxford in collaboration with five Universities in England (Birmingham, Liverpool, Newcastle, and Sheffield). This is a longitudinal observational cohort study of healthcare workers that seeks to understand the immune system's response to COVID-19, whether induced by vaccination or natural exposure to the virus. Antibody responses to SARS-CoV-2 are important but other parts of the immune response are necessary for protection against getting ill. T cells, which are a subset of the body’s white blood cells, are crucial for directing the immune response (including co-ordinating antibodies) and also fight the virus once it has infected cells. However, T cells are harder to measure because specialist skills and equipment are needed and therefore most studies focus on antibodies. PITCH-2 takes a comprehensive look at the immune system, measuring antibodies, T cells and other cellular responses in the blood stream, and also looks at the local immune response in the nose (mucosal immunity). The role of antibodies, T cells and other cellular immune responses in protection against future infections with SARS-CoV-2 remains unknown, and lasting immunity to COVID-19 is yet to be determined. Therefore, detailed examination of the immune system among healthcare workers is essential to provide critical information for vaccine design and future public health policies, including the need for further booster vaccines. More details and study publications can be found on the PITCH study website PITCH Study (pitch-study.org).

Episode thumbnail for Variation across the human genome: a tricky balancing act in human health and disease

February 10, 2016

Variation across the human genome: a tricky balancing act in human health and disease

Genetic variation can have opposing effects on human disease, where the benefits of a protective variant against one disease can increase the risk of another. I provided four examples of the Yin/Yang of genetic variation in human health and disease: CCR5Δ32: This variant protects against HIV-1, but associates with risk of symptomatic West Nile Virus infection. HLA-B*57: this is an HLA class I allele of the highly polymorphic HLA-B gene that confers protection against HIV-1, but associates with risk of psoriasis and abacavir hypersensitivity. HLA-C expression levels: complex variation outside of the protein coding region of the HLA-C gene determines HLA-C expression levels, where high expression associates with protection against HIV-1, but it also confers risk of Crohn’s Disease and graft vs. host disease after transplantation. Killer cell immunoglobulin-like receptors that confer activating states: These complex genotypes confer protection against KSHV infection, but among subjects with these genotypes who do become infected with KSHV, there is an increased risk of Kapok’s sarcoma.

Episode thumbnail for Science in a crisis, fast-forwarding clinical research for Ebola

December 2, 2015

Science in a crisis, fast-forwarding clinical research for Ebola

Professor Peter Horby's research focuses on epidemic diseases such as Ebola and bird flu, and crosses the disciplines of basic science, medical science and public health. Professor Peter Horby, who was recently awarded a UK Government Ebola Medal for Service in West Africa for his role in fighting the 2015 Ebola outbreak, talks about the history and science of Ebola. This public lecture was given as part of Oxford Open Doors, on the 12th September 2015.

10 total episodes available

Deep-dive analytics for NDM Public Engagement

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is NDM Public Engagement?

The NDM recognises that public engagement is vital in order to educate, inform and build a relationship with the community. Our scientists are actively engaging in open discussion, and meeting people to debate, listen and learn.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.